Your browser doesn't support javascript.
loading
Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.
Litten, Raye Z; Falk, Daniel E; Ryan, Megan L; Fertig, Joanne; Leggio, Lorenzo.
Affiliation
  • Litten RZ; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Falk DE; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Ryan ML; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Fertig J; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
  • Leggio L; Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
Alcohol Clin Exp Res ; 44(1): 23-35, 2020 01.
Article in En | MEDLINE | ID: mdl-31803968
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alcohol Deterrents / Alcoholism / Drug Industry / National Institute on Alcohol Abuse and Alcoholism (U.S.) / Precision Medicine / Drug Development Type of study: Prognostic_studies Limits: Animals / Humans Country/Region as subject: America do norte Language: En Journal: Alcohol Clin Exp Res Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alcohol Deterrents / Alcoholism / Drug Industry / National Institute on Alcohol Abuse and Alcoholism (U.S.) / Precision Medicine / Drug Development Type of study: Prognostic_studies Limits: Animals / Humans Country/Region as subject: America do norte Language: En Journal: Alcohol Clin Exp Res Year: 2020 Type: Article